Evaluating the post-licensure effectiveness of a group B meningococcal vaccine in New Zealand: a multi-faceted strategy

S Ameratunga, A Macmillan, J Stewart, D Scott, Edward (Kim) MULHOLLAND, S Crengle, Meningoccal Management Team

Research output: Contribution to journal › Article

Ameratunga, S., Macmillan, A., Stewart, J., Scott, D., MULHOLLAND, E. K., Crengle, S., & Meningoccal Management Team (2005). Evaluating the post-licensure effectiveness of a group B meningococcal vaccine in New Zealand: a multi-faceted strategy. Vaccine, 23, 2231-2234.

@article{d1fbcf9cb752459398a22aab000fcef2,

title = "Evaluating the post-licensure effectiveness of a group B meningococcal vaccine in New Zealand: a multi-faceted strategy",

author = "S Ameratunga and A Macmillan and J Stewart and D Scott and MULHOLLAND, {Edward (Kim)} and S Crengle and {Meningoccal Management Team}",

year = "2005",

language = "English",

volume = "23",

pages = "2231--2234",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier",

}

TY - JOUR

T1 - Evaluating the post-licensure effectiveness of a group B meningococcal vaccine in New Zealand

T2 - a multi-faceted strategy

AU - Ameratunga, S

AU - Macmillan, A

AU - Stewart, J

AU - Scott, D

AU - MULHOLLAND, Edward (Kim)

AU - Crengle, S

AU - Meningoccal Management Team, null

PY - 2005

Y1 - 2005

M3 - Article

VL - 23

SP - 2231

EP - 2234

JO - Vaccine

JF - Vaccine

SN - 0264-410X

ER -